Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
44,586,943
-
Share change
-
-125,822
-
Total reported value
-
$2,405,632,656
-
Put/Call ratio
-
470%
-
Price per share
-
$53.95
-
Number of holders
-
229
-
Value change
-
-$6,236,173
-
Number of buys
-
87
-
Number of sells
-
113
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2019
As of 31 Dec 2019,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,586,943 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, STATE STREET CORP, EARNEST PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, SNYDER CAPITAL MANAGEMENT L P, GOLDMAN SACHS GROUP INC, RICE HALL JAMES & ASSOCIATES, LLC, and NORTHERN TRUST CORP.
This page lists
229
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.